Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

The Biden administration proposed a rule to let Medicare and Medicaid cover obesity drugs like Ozempic. Millions would ...

The Biden administration has proposed a new rule that would allow Medicare and Medicaid to cover popular weight-loss ...

美国政府近日宣布了一项关于联邦医疗保险（Medicare）和联邦医疗补助（Medicaid）的重大提案，将Wegovy和Ozempic等减肥药物纳入承保范围，预计将有740万人从中受益。这项提议不仅反映了当前社会对肥胖症治疗的关注，也揭示了美国医疗保障体系长期以来的发展历程。 自20世纪60年代初，美国总统林登·约翰逊签署《社会保障法》修正案，正式建立了Medicare和Medicaid两个项目以 ...

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...

当地时间周二，美国白宫在官网宣布，拜登政府推出提案，要求联邦医疗保险（Medicare）和联邦医疗补助（Medicaid）将Wegovy和Ozempic等“减肥神药”纳入承保范围。据媒体报道，这是一项成本高昂但可能广受欢迎的举措，需要特朗普的支持才能 ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...